30 reports

EMERGING INFECTIOUS DISEASES; ##(##): ##-##.

  • Influenza
  • Market Size
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation
  • 37.1 NEW ZEALAND SEASONAL INFLUENZA VACCINATED TOTAL POPULATION

One of the risk groups is the elderly, among whom Latvia has one of the lowest influenza vaccination coverage rates of nearly ##-## percent while WHO and the European Centre for Disease Control (ECDC) recommend ## percent for this age group to be vaccinated.

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • GLOBAL ANTIVIRAL DRUGS MARKET SEGMENTATION BY THERAPIES

OTHER CAUSES INCLUDE HEAVY CONSUMPTION OF ALCOHOL, TOXINS, MEDICATIONS, AND OTHER INFECTIONS SUCH AS HIV AND AUTOIMMUNE DISEASES.

  • Influenza
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • ViiV Healthcare Ltd.
  • throughout the US.

MedImmune LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report...

  • Influenza
  • Lung Cancer
  • Pharmaceutical
  • United States
  • MedImmune, LLC

The company utilizes injectable interferon, an FDA-approved technology to develop drugs for the treatment of neoplastic, viral and autoimmune diseases.

  • Influenza
  • Therapy
  • United States
  • World
  • Product Initiative

The first therapeutic target is Graves' disease, an autoimmune condition resulting in hyperthyroidism.

  • Influenza
  • Vaccine
  • United States
  • Company
  • EpiVax, Inc.
  • INFLUENZAVIRUS B INFECTIONS - PIPELINE BY ADIMMUNE CORP, H1 2018
  • INFLUENZAVIRUS B INFECTIONS - PIPELINE BY ALTRAVAX INC, H1 2018

The company' s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer.

  • Influenza
  • Australia
  • United States
  • World
  • Product Initiative
  • INFLUENZA [STRAINS A/H1N1 + A/H3N2 + A/H5N1] VACCINE - DRUG PROFILE
  • EMERGENT BIOSOLUTIONS INC

The company' s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer.

  • Influenza
  • Pathology
  • Vaccine
  • United States
  • Product Initiative
  • INFLUENZA A VIRUS, H1N1 SUBTYPE INFECTIONS - PIPELINE BY ALTIMMUNE INC, H2 2018
  • INFLUENZA [STRAINS A/H1N1 + A/H3N2 + A/H5N1] VACCINE - DRUG PROFILE

It' s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer.

  • Influenza
  • Pathology
  • Vaccine
  • United States
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Influenza
  • Vaccine
  • World
  • Product Initiative
  • INFLUENZAVIRUS B INFECTIONS - PIPELINE BY ALTRAVAX INC, H2 2018
  • INFLUENZAVIRUS B INFECTIONS - PIPELINE BY ADIMMUNE CORP, H2 2018

It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases.

  • Influenza
  • Therapy
  • Vaccine
  • United States
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Influenza
  • World
  • Product Initiative
  • GlaxoSmithKline plc
  • INFLUENZA [STRAINS A/H1N1 + A/H3N2 + A/H5N1] VACCINE - DRUG PROFILE

The target Influenza viruses are Influenza A viruses, the transmembrane proteins are comprised of one or more different HA subtypes ## -## and / or NA subtypes ## -## ##.

  • Influenza
  • Vaccine
  • United States
  • Product Initiative
  • BiondVax Pharmaceuticals Ltd.

ALS, also known as Lou Gehrig' s, is one such disease.

  • Influenza
  • Pharmaceutical
  • Therapy
  • Vaccine
  • United States
  • R&D Progress

IN 2003, CEL-SCI CORPORATION WAS AWARDED RESEARCH GRANT OF USD ##, ## FROM NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (##R##HL##-##A##) FOR THE PROJECT ENTITLED PEPTIDE VACCINE FOR EXPERIMENTAL AUTOIMMUNE MYOCARDITIS".

  • Influenza
  • United States
  • World
  • Product Initiative
  • BiondVax Pharmaceuticals Ltd.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Hoffmann-La Roche Ltd Microgen Scientific Industrial Company for Immunobiological ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Medicines ## ## ## ## ## ## ## ## Altimmune Inc ## ## ## ## ## ## ## ## CSL Ltd Source: GlobalData' s Pharma Intelligence Center C

  • Drug Discovery And Development
  • Influenza
  • World
  • Product Initiative
  • GlaxoSmithKline plc
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Influenza
  • Vaccine
  • World
  • GlaxoSmithKline plc
  • INFLUENZA [STRAINS A/H1N1 + A/H3N2 + A/H5N1] VACCINE - DRUG PROFILE
  • INFLUENZA A VIRUS, H3N2 SUBTYPE INFECTIONS - PIPELINE BY CONTRAFECT CORP, H2 2018

It' s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer.

  • Influenza
  • Vaccine
  • United States
  • Product Initiative
  • BiondVax Pharmaceuticals Ltd.
  • R&D Progress
  • CUREVAC AG

The company' s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer.

  • Influenza
  • Therapy
  • Vaccine
  • United States
  • Product Initiative
  • EPIVAX, INC. - RECENT PIPELINE UPDATES, 2016

Novozymes Biopharma and EpiVax announced that they have entered a license agreement for the development of treatments for autoimmune diseases.

  • Influenza
  • Vaccine
  • United States
  • Company Operations
  • EpiVax, Inc.

Its products are used in the therapeutic areas of psoriatic arthritis, multiple sclerosis, lupus, rheumatoid arthritis, and other autoimmune diseases, chronic pain and multiple viral diseases respectively.

  • Influenza
  • Vaccine
  • United States
  • Company Operations
  • Hemispherx Biopharma, Inc.
  • INFLUENZA A VIRUS, H3N2 SUBTYPE INFECTIONS - PIPELINE BY CELLTRION INC
  • INFLUENZA A VIRUS, H1N1 SUBTYPE INFECTIONS - PIPELINE BY EMERGENT BIOSOLUTIONS INC

THE COMPANY' S PRODUCT PORTFOLIO INCLUDES VACCINES AND ANTIBODY THERAPEUTICS WITH FOCUS ON INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND CANCER.

  • Influenza
  • Vaccine
  • United States
  • Product Initiative
  • Sanofi S.A.

ANAPTYSBIO INC (ANAPTYSBIO) IS A CLINICAL-STAGE BIOTECHNOLOGY COMPANY THAT FOCUSES ON THE DEVELOPMENT OF ANTIBODY PRODUCT CANDIDATES FOR THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND ATOPIC DISEASES.

  • Cough And Cold
  • Influenza
  • Therapy
  • United States
  • Product Initiative

UNDER THE TERMS OF THE AGREEMENT, DAIICHI SANKYO AND COHERUS BIOSCIENCES WILL WORK TOGETHER TO DEVELOP, MANUFACTURE AND COMMERCIALIZE BIOSIMILARS FOR ANTI-TNF-ALPHA DRUG ENBREL FOR AUTOIMMUNE DISORDERS DEVELOPED BY COHERUS BIOSCIENCES, INC.

  • Breast Cancer
  • Influenza
  • Monoclonal Antibody
  • Therapy
  • Daiichi Sankyo Company
  • Drug Profiles

These are projected to apply to a wide variety of disorders, including cancer, infectious disease, and autoimmune disease.

  • Influenza
  • United States
  • Company
  • Product Initiative
  • Hemispherx Biopharma, Inc.
  • H1N1 INFECTION - PIPELINE BY EPIVAX, INC., H1 2016
  • Drug Profiles

H1N1 Infection - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H1 2016’, provides an overview of the H1N1 Infection pipeline landscape. The report provides comprehensive information on the therapeutics under development for H1N1 Infection, complete with analysis by...

  • Influenza
  • Research And Development
  • Vaccine
  • United States
  • Company Operations
  • Drug Profiles

These are projected to apply to a wide variety of disorders, including cancer, infectious disease, and autoimmune disease.

  • Influenza
  • Vaccine
  • United States
  • Company Operations
  • NanoViricides, Inc.
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Influenza
  • Vaccine
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

Hoffmann-La Roche Ltd. ## ## ## ## ## ## ## ## Daiichi Sankyo Company, Limited ## ## ## ## ## ## ## ## Altimmune, Inc. ## ## ## ## ## ## ## ## CSL Limited ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma eTrack Clinical Trials Database (*)Trials are t

  • Clinical Trial
  • Infectious Disease
  • Influenza
  • Pharmaceutical
  • World
  • H5N1 INFECTION (AVIAN INFLUENZA) - PIPELINE BY EMERGENT BIOSOLUTIONS INC., H2 2015
  • Drug Profiles

These are projected to apply to a wide variety of disorders, including cancer, infectious disease, and autoimmune disease.

  • Influenza
  • United States
  • Company
  • Product Initiative
  • Hemispherx Biopharma, Inc.